Takeda Escapes Antitrust Suit Over IBS Drug
A Massachusetts federal judge on Monday tossed a Blue Cross affiliate's proposed class action against Takeda Pharmaceuticals over an alleged conspiracy to keep generic versions of constipation drug Amitiza off the...To view the full article, register now.
Already a subscriber? Click here to view full article